MMP-9-IN-7
Product Specifications
UNSPSC Description
MMP-9-IN-7 is a potent MMP9 inhibitor with an IC50 of 0.52 μM in proMMP9/MMP3 P126 activation assay. MMP-9-IN-7 is extracted from patent WO2012162468 (example 59), and can be used for MMP9/MMP13 mediated syndrome research[1].
Target Antigen
MMP
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mmp-9-in-7.html
Solubility
10 mM in DMSO
Smiles
O=C(C)NC1=NC(C)=C(C2=CSC(NC3=CC(Cl)=CC=C3OC)=N2)S1
Molecular Weight
394.90
References & Citations
[1]Paul Francis Jackson, et al. Thiazol derivatives as pro -matrix metalloproteinase inhibitors. Patent WO2012162468.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-153913/MMP-9-IN-7-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-153913/
Clinical Information
No Development Reported
CAS Number
333746-76-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6259294-01 0.1 mL
Tau (Tau Protein, Microtubule-associated Protein, MAP) (MaxLight 490)
Ask
View Details 
MBS6259294-02 5x 0.1 mL
Tau (Tau Protein, Microtubule-associated Protein, MAP) (MaxLight 490)
Ask
View Details MBS1018785-01 0.02 mg (E-Coli)
Recombinant Streptococcus pneumoniae D-alanine--D-alanine ligase (ddl)
Ask
View Details MBS1018785-02 0.02 mg (Yeast)
Recombinant Streptococcus pneumoniae D-alanine--D-alanine ligase (ddl)
Ask
View Details MBS1018785-03 0.1 mg (E-Coli)
Recombinant Streptococcus pneumoniae D-alanine--D-alanine ligase (ddl)
Ask
View Details